Avantika Gupta

avantikagupta.bsky.social

11 November 2025 02:14

More mechanisms of resistance to anti-HER2 ADCs, this time with a focus on loss of target interaction!

Prasad Jallepalli, MD, PhD

prasad.bsky.social

05 June 2025 00:27

our lightsaber

Memorial Sloan Kettering Cancer Center

mskcancercenter.bsky.social

17 May 2025 00:42

🚨 NEW in @natgenet.nature.com: MSK's Dr. Sarat Chandarlapaty and colleagues investigates how APOBEC3 #mutagenesis drives therapy resistance in #BreastCancer. Learn more: www.nature.com/articles/s41...

Avantika Gupta

avantikagupta.bsky.social

16 May 2025 13:22

So excited to share our latest work with @saratchandarlapaty.bsky.social, Antonio Marra, Andrea Gazzo @mskcancercenter.bsky.social out today in @natgenet.nature.com! We uncover the function and mechanism of APOBEC3-driven therapy resistance in breast cancer. 🧵 1/ www.nature.com/articles/s41...

Memorial Sloan Kettering Cancer Center

mskcancercenter.bsky.social

01 May 2025 10:14

Join breast medical oncologist Dr. Sarat Chandarlapaty for a major symposium titled “Mutational processes and therapy resistance in breast cancer” today at #AACR25. Learn more: bit.ly/42PdiVE